- Home
- IPHA vs PRE Comparison
IPHA vs PRE Comparison
Compare IPHA & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- PRE
- Stock Information
- Founded
- IPHA 1999
- PRE 2014
- Country
- IPHA France
- PRE Hong Kong
- Employees
- IPHA N/A
- PRE N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- IPHA Health Care
- PRE Industrials
- Exchange
- IPHA Nasdaq
- PRE Nasdaq
- Market Cap
- IPHA 160.1M
- PRE 131.3M
- IPO Year
- IPHA 2019
- PRE N/A
- Fundamental
- Price
- IPHA $2.18
- PRE $16.95
- Analyst Decision
- IPHA Hold
- PRE Buy
- Analyst Count
- IPHA 2
- PRE 1
- Target Price
- IPHA $2.00
- PRE $9.00
- AVG Volume (30 Days)
- IPHA 12.3K
- PRE 129.5K
- Earning Date
- IPHA 09-17-2025
- PRE 11-26-2025
- Dividend Yield
- IPHA N/A
- PRE N/A
- EPS Growth
- IPHA N/A
- PRE N/A
- EPS
- IPHA N/A
- PRE N/A
- Revenue
- IPHA $14,839,695.00
- PRE $57,051,000.00
- Revenue This Year
- IPHA $50.89
- PRE $202.46
- Revenue Next Year
- IPHA N/A
- PRE $103.60
- P/E Ratio
- IPHA N/A
- PRE N/A
- Revenue Growth
- IPHA N/A
- PRE 151.74
- 52 Week Low
- IPHA $1.29
- PRE $3.10
- 52 Week High
- IPHA $3.51
- PRE $17.99
- Technical
- Relative Strength Index (RSI)
- IPHA 60.94
- PRE 63.96
- Support Level
- IPHA $2.07
- PRE $14.50
- Resistance Level
- IPHA $2.28
- PRE $17.45
- Average True Range (ATR)
- IPHA 0.09
- PRE 1.34
- MACD
- IPHA 0.01
- PRE 0.04
- Stochastic Oscillator
- IPHA 69.70
- PRE 72.12
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.